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Genetic Diseases of Junctions
Joey E. Lai-Cheong1, Ken Arita1,2 and John A. McGrath1
Tight junctions, gap junctions, adherens junctions, and desmosomes represent intricate structural intercellular
channels and bridges that are present in several tissues, including epidermis. Clues to the important function of
these units in epithelial cell biology have been gleaned from a variety of studies including naturally
occurring and engineered mutations, animal models and other in vitro experiments. In this review, we focus
on mutations that have been detected in human diseases. These observations provide intriguing insight
into the biological complexities of cell–cell contact and intercellular communication as well as demonstrating
the spectrum of inherited human diseases that are associated with mutations in genes encoding the component
proteins. Over the last decade or so, human gene mutations have been reported in four tight junction
proteins (claudin 1, 14, 16, and zona occludens 2), nine gap junction proteins (connexin 26, 30, 30.3, 31, 32, 40, 43,
46, and 50), one adherens junction protein (P-cadherin) and eight components of desmosomes (plakophilin
(PKP) 1 and 2, desmoplakin, plakoglobin – which is also present in adherens junctions, desmoglein (DSG)
1, 2, 4, and corneodesmosin). These discoveries have often highlighted novel or unusual phenotypes,
including abnormal skin barrier function, alterations in epidermal differentiation, and developmental anomalies
of various ectodermal appendages, especially hair, as well as a range of extracutaneous pathologies.
However, this review focuses mainly on inherited disorders of junctions that have an abnormal skin
phenotype.
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Introduction
To maintain the structure and function
of the epidermis a number of inter-
cellular junctions exist, including tight
junctions, gap junctions, adherens
junctions, and desmosomes. These
cell–cell contacts have multiple and
diverse roles in regulating aspects of
tissue adhesion, signaling, communica-
tion, differentiation, migration, prolif-
eration, shape, permeability, polarity,
and development. Each junction is
made up of complex networks of
proteins, the precise composition of
which may vary in a site-specific and
differentiation-specific manner. In re-
cent years, a number of naturally
occurring human mutations have been
detected in genes that encode several
proteins that make up these junctions.
In this review, we highlight the natu-
rally occurring human mutations that
constitute the ‘‘genetic disorders of
junctions’’. Mutations in components
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PERSPECTIVE
Editor’s Note
The JID Perspectives Series on keratinocyte adhesion and
cell junctions continues with a review of the mutations
that occur in important proteins that make up the
intercellular junctions of keratinocytes. In this issue, Lai-
Cheong and coworkers provide a comprehensive review
of human genetic diseases that have been found to arise
from mutations of intercellular junction proteins. This
review highlights the important collaborations that have
developed in investigative dermatology among cell
biologists, geneticists, and clinicians. This Perspective
provides direct evidence of how the close interactions
of these scientific teams – working both from bench to
bedside and from bedside to bench – have led to the
discovery of new molecules important in keratinocyte
adhesion, an increased understanding of the mechanisms
of many genetic diseases, and new approaches for the
treatment of some of the most severe inherited diseases of
the skin.
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of tight junctions, gap junctions, ad-
herens junctions, and desmosomes are
described, although some mutated pro-
teins, such as plakoglobin, are integral
to both adherens junctions and desmo-
somes.
Tight junctions
Tight junctions have important roles in
regulating epidermal barrier permeabil-
ity by regulating the paracellular flux of
water-soluble molecules between ad-
jacent cells. The principal structural
protein of tight junctions are the
claudins, of which there are approxi-
mately 24 subtypes. Each of the clau-
dins shows a unique tissue expression
pattern with the main claudins in
epidermis being claudin 1 and 4
(Furuse and Tsukita, 2006). Claudins
also bind to other membrane macro-
molecules, including the zona occlu-
dens (ZO) proteins ZO-1, ZO-2, ZO-3,
and multi-PDZ domain protein-1. Mu-
tations in human claudin genes were
first identified in 1999. Simon et al.
(1999) reported one nonsense and a
number of missense mutations in clau-
din 16 (also known as paracellin-1) in
subjects with a rare autosomal-reces-
sive renal disorder, familial hypomag-
nesemia with hypercalciuria and
nephrocalcinosis (OMIM248250); sev-
eral other mutations in the claudin 16
gene, CLDN16, in this condition have
subsequently been reported (Weber
et al., 2001), but no skin abnormalities
have been noted in any affected
individual. Apart from the kidney, tight
junctions have key roles in other
organs, including the ear and liver.
Mutations in the claudin 14 gene,
CLDN14, have been shown to underlie
the autosomal-recessive deafness dis-
order DFNB29 leading to cochlear hair
cell degeneration (Wilcox et al., 2001).
Mutations in the gene encoding the
ZO-2 protein (also known as tight
junction protein 2) have been reported
as the basis for some cases of familial
hypercholanemia, emphasizing the
role of tight junctions in bile duct
physiology (Carlton et al., 2003). A
rare X-linked neurodevelopmental dis-
order with congenital cataracts, Nan-
ce–Horan syndrome (OMIM302350),
results from mutations in the gene
encoding the Nance–Horan syndrome
protein (Burdon et al., 2003) which
colocalizes with ZO-1 in tight junc-
tions (Sharma et al., 2006). However,
dermatologic manifestations of inher-
ited tight junction mutations are limited
to genetic disorders of claudin 1.
Claudin-1
In 2002, Baala et al. (2002) mapped an
unusual syndromic form of ichthyosis
in consanguineous Moroccan families
to a locus on chromosome 3q27–28.
The cutaneous features comprised dif-
fuse ichthyosis with large scales, hypo-
trichosis, and scarring alopecia as well
as hypodontia. Other clinical abnorm-
alities included sclerosing cholangitis
and the disorder was termed neonatal
ichthyosis and sclerosing cholangitis
(OMIM607626). Vacuoles were noted
in the affected individuals’ eosinophils
(and to a lesser extent basal keratino-
cytes). In addition, ultrastructural ab-
normalities were observed in the
granular layer of the epidermis with
disruption of intercellular connections,
although widening of desmosomal pla-
ques was the most prominent finding
(Baala et al., 2002). Given that the region
of linkage in these families contained the
claudin 1 gene, CLDN1, and that there
were clear similarities between the hu-
man disease and the phenotype of mice
deficient in claudin 1 (Furuse et al.,
2002), claudin 1 was a prime candidate
for this disease and the first naturally
occurring tight junction gene mutations
with a skin phenotype were reported in
2004 (Hadj-Rabia et al., 2004). Affected
individuals were found to have a homo-
zygous 2-bp deletion (201_202del) in
exon 1 of CLDN1 leading to complete
loss of expression of this tight junction
protein (Hadj-Rabia et al., 2004). This
mutation demonstrates the very impor-
tant role of claudin 1 in human skin and
liver biology.
Gap junctions
The first inherited abnormality of a gap
junction protein was reported in 1993
with mutations in connexin 32 (en-
coded by the GJB1 gene) in individuals
with X-linked Charcot–Marie–Tooth
disease (OMIM302800) (Bergoffen
et al., 1993). Then in 1997, mutations
in the GJB2 gene (encoding connexin
26) were identified in cases of con-
genital sensorineural deafness (DFNA3,
OMIM601544; DFNB1, OMIM220290)
(Kelsell et al., 1997), a finding that led
to the significant discovery that muta-
tions in GJB2 are in fact a common
cause of several forms of congenital
deafness. Subsequently, mutations
have been discovered in seven other
connexin genes: GJB3 (connexin 31),
GJB4 (connexin 30.3), GJB6 (connexin
30), GJA1 (connexin 43), GJA3 (con-
nexin 46), GJA8 (connexin 50), and
most recently, GJA5 (connexin 40)
(Figure 1). Of these, four connexins
are associated with skin diseases: con-
nexins 26, 30, 30.3, and 31, although
mutations in connexin 43 can also
result in hair (and occasionally skin)
abnormalities. Mutations in connexins
46 and 50 have been shown to underlie
cases of zonular pulverent cataract,
types CZP3 (OMIM601885) and CZP1
(OMIM116200), respectively (Berry
et al., 1999; MacKay et al., 1999).
Connexin 40 mutations have been
implicated in some cases of idiopathic
atrial fibrillation with somatic muta-
tions in cardiac tissue or as a germline
mutation (Gollob et al., 2006).
Connexin 26
Mutations in GJB2, which encodes
Cx26, can result in several distinct skin
disorders including Vohwinkel’s syn-
drome, keratitis–ichthyosis–deafness
(KID) syndrome, Bart–Pumphrey syn-
drome (BPS), and syndromic sensori-
neural hearing loss with keratoderma
(Figure 2a). The clinical abnormalities
resulting from Cx26 mutations vary
considerably but often involve skin
hyperkeratosis (particularly palmoplan-
tar keratoderma) and/or sensorineural
deafness, usually with autosomal-
dominant inheritance. The first connex-
in 26 mutation in a skin disease was
described in a case of palmoplantar
keratoderma with deafness (Richard
et al., 1998b). The genetic abnormality
was a heterozygous missense mutation,
p.R75W, which occurs within the
second transmembranous domain. In
vitro transfection studies showed this to
be a dominant-negative mutation that
disrupts normal connexon and gap
junction function (Richard et al.,
1998b). Subsequently, three other mis-
sense mutations (p.G59A, p.G59R, and
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p.R75Q) have been reported with this
phenotype (Heathcote et al., 2000;
Uyguner et al., 2002; Leonard et al.,
2005). Of note, the p.G59R case also
had knuckle pads, suggesting phenoty-
pic similarity to BPS (see below)
(Leonard et al., 2005). The second
report of a connexin 26 mutation in a
genodermatosis was made by Maestrini
et al. (1999) in a case of Vohwinkel’s
syndrome (OMIM124500). Vohwin-
kel’s syndrome is an autosomal-domi-
nant disorder comprising palmoplantar
keratoderma and pseudoainhum lead-
ing to autoamputation of digits, as well
as varying degrees of sensorineural
deafness. A heterozygous missense
mutation, p.D66H, was identified in a
large British pedigree containing 10
affected members. This connexin 26
mutation involves a residue within the
first extracellular domain and is pre-
dicted to disrupt the assembly of
connexin 26 into connexons as well
as the docking and gating properties of
the resulting gap junction. In 2002, a
further connexin 26 genodermatosis
was identified with the discovery of
heterozygous missense mutations
(p.G12R, p.S17F, and p.D50N) in KID
syndrome (OMIM148210) (Richard
et al., 2002). KID syndrome is char-
acterized by the triad of keratitis,
hyperkeratotic plaques (mainly on the
scalp and extremities, particularly
palms and soles), and profound bilat-
eral sensorineural hearing loss. The
p.D50N mutation occurs within the
highly conserved extracellular loop of
connexin 26, an area critical for
voltage gating (Rubin et al., 1992),
whereas the other two mutations
(p.G12R and p.S17F) affect the cyto-
plasmic amino terminus and may dis-
rupt the regulation of connexin
selectivity and gating polarity (Verselis
et al., 1994; Falk et al., 1997; Purnick
et al., 2000). The p.D50N mutation has
also been reported subsequently in a
case of hystrix-like-ichthyosis-deafness
syndrome (OMIM602540), which clini-
cally resembles KID syndrome (van
Geel et al., 2002). In addition, four
other heterozygous mutations in the
GJB2 gene (p.N14Y, p.A40V, p.G45E,
and p.D50Y) have been reported in
other cases of KID syndrome (Yotsu-
moto et al., 2003; Montgomery et al.,
2004; Janecke et al., 2005; Arita et al.,
2006). Additional clinical features of a
severe follicular occlusion triad were
reported in two of these KID syndrome
cases (p.A40V and p.D50N) (Mon-
tgomery et al., 2004; Maintz et al.,
2005). In 2004, BPS (OMIM149200)
was added to the spectrum of connexin
26 mutation-related disorders (Richard
et al., 2004). BPS (BPS) is an auto-
somal-dominant condition character-
ized by the combination of
palmoplantar keratoderma, sensori-
neural deafness, knuckle pads, and
leukonychia (Bart and Pumphrey,
1967). Richard et al. (2004) identified
a heterozygous missense mutation,
p.N54K, within the first extracellular
domain. Subsequently, the mutation
p.G59S was reported in another case
of BPS (Alexandrino et al., 2005).
Mutations affecting p.G59 have also
been reported in two cases of palmo-
plantar keratoderma with deafness
(Heathcote et al., 2000; Leonard
et al., 2005), suggesting clinical hetero-
geneity resulting from mutations in this
residue of connexin 26. Expanding the
clinical spectrum of connexin 26 dis-
orders even further, the mutation
p.N14K has been reported in a case of
a Clouston’s syndrome-like disorder
associated with deafness (van Steensel
et al., 2004), although a mutation in
this amino acid has also been described
in KID syndrome (Arita et al., 2006). In
addition, the mutation p.F142L, which
occurs within the third transmembra-
nous domain of connexin 26, has been
documented in a case of deafness
associated with unusual mucocuta-
neous findings, including a psoriasi-
form dermatitis, oral erosions, and ear
infections (Brown et al., 2003). Clearly
mutations in the GJB2 gene are asso-
ciated with protean clinical abnormal-
ities. Moreover, genotype–phenotype
correlation is difficult. For example,
although in most cases of KID syn-
drome the connexin 26 pathology is
close to the amino terminus, some
cases of nonsyndromic deafness also
involve similar mutations, for example,
p.W44C (Denoyelle et al., 1998).
Moreover, particular mutations can be
associated with different clinical phe-
notypes, as seen for the p.D50N
and p.G45E mutations. Of note,
p.G45E has been reported in KID
syndrome patients (Janecke et al.,
2005), but this is also one of the most
common mutations in nonsyndromic
Bart–Pumphrey
syndrome
Palmoplantar
keratoderma
with deafness
Deafness with
unusual
hyperkeratosis
and oral erosions
Deafness with
Clouston-like
phenotype
Hystrix-like-
ichthyosis-
deafness
syndrome
Keratitis
ichthyosis-
deafness
syndrome Non-syndromic
deafness
Non-syndromic
deafness
Peripheral
neuropathy
and hearing
impairment
Non-syndromic
deafness
Atrial
fibrillation
Non-syndromic
deafness
Zonular
pulverulent
cataract-3
Vohwinkel's
syndrome
Clouston's
syndrome
Erythro-
keratoderma
variabilis
Erythro-
keratoderma
variabilis
Charcot–Marie-
Tooth disease
(X-linked)
Oculodentodigital
dysplasia
Zonular
pulverulent
cataract-1
26 30 30.3 31 32 40 43 46 50
Figure 1. Illustration of disease phenotypes associated with abnormal gap junctions owing to inherited mutations in connexins. Most connexin disorders are
autosomal dominant, although mutations in connexins 26, 31, and 43 can be associated with autosomal-recessive forms of deafness. In addition, recessive
mutations in connexin 31 may underlie rare, recessive cases of EKV, and inheritance of connexin 32 mutations in Charcot–Marie–Tooth disease is X-linked.
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autosomal-recessive deafness in
Japanese individuals (Ohtsuka et al.,
2003).
Connexin 31
The first connexin 31 mutation (GJB3
gene) was reported in a case of
erythrokeratoderma variabilis (EKV;
OMIM133200) (Richard et al., 1998a)
(Figure 2b). EKV characterized by
transient figurate erythema and loca-
lized or generalized hyperkeratosis
that develops soon after birth. EKV is
usually an autosomal-dominant disor-
der, although recessive cases have also
been reported (Gottfried et al., 2002;
Terrinoni et al., 2004). In the report by
Richard et al. (1998a) three heterozy-
gous missense mutations, p.G12R,
p.G12D, and p.C86S, were detected
in four autosomal-dominant families
with EKV (Richard et al., 1998a);
additional amino-acid substitutions in
connexin 31, p.R42P, p.F137L, and
p.L209F, have also been reported in
other EKV subjects (Richard et al.,
2000; Morley et al., 2005). In 2002,
Gottfried et al. (2002) reported the first
autosomal-recessive EKV mutation with
a homozygous mutation p.L34P which
resulted in defective trafficking of con-
nexin 31. An additional case of reces-
sive EKV associated with the missense
mutation p.E100K has also been re-
ported (Terrinoni et al., 2004).
Although none of the reported EKV
cases (dominant or recessive) has hear-
ing impairment, mutations in connexin
31 have also been reported in familial
cases of autosomal-dominant hearing
impairment as well as autosomal-re-
cessive hearing loss and peripheral
neuropathy associated with hearing
impairment (Xia et al., 1998; Rabionet
et al., 2000; Lopez-Bigas et al., 2001).
Connexin 30.3
Adding to the genetic heterogeneity of
EKV, mutations in the GJB4 gene,
encoding connexin 30.3, were reported
in 2000 (Macari et al., 2000) (Figure
2c). These authors documented a het-
erozygous missense mutation, p.F137L,
and other amino-acid substitutions in
individuals with EKV, p.G12D,
p.R22H, p.T85P, and p.F189Y, were
also reported (Richard et al., 2003). Of
note, identical mutations (p.F137L and
p.G12D) have been reported in con-
nexin 31 in individuals with the same
EKV phenotype. This observation sug-
gests both a specific genotype–pheno-
type correlation between these
mutations and EKV, but also a very
similar function for connexins 30.3 and
31 in skin biology (Richard et al.,
1998a, 2000).
Connexin 30
Although a pathogenic mutation in the
GJB6 gene had been found in cases of
autosomal-dominant nonsyndromic
sensorineural deafness in 1999 (Grifa
et al., 1999), an association with
inherited skin disease was not docu-
mented until the following year. La-
martine et al. (2000) reported the first
examples of connexin 30 mutations in
individuals with hidrotic ectodermal
dysplasia (Clouston syndrome;
OMIM129500) (Figure 2d). Clouston
syndrome is an autosomal-dominant
form of ectodermal dysplasia charac-
terized by nail dystrophy, palmoplantar
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Figure 2. Mutation spectrum and skin disease phenotypes for the gap junction proteins connexin 26,
30, 30.3, and 31. Mutations associated with hearing loss/impairment in the absence of skin
abnormalities are not shown (a) Mutations in connexin 26: 16 different mutations have been associated
with various clinical abnormalities, including KID syndrome (black), palmoplantar keratoderma with
deafness (red), Vohwinkel’s syndrome (blue), BPS (purple), Clouston’s syndrome-like disorder with
deafness (green), and deafness with hyperkeratosis, oral erosions and other unusual mucocutaneous
abnormalities (brown). Asterisk indicates a hystrix-like ichthyosis-deafness disorder has been reported
with this mutation. (b) Mutations in connexin 31: eight different missense mutations have been identified
in connexin 31. The majority have been associated with autosomal-dominant EKV, although the purple
text indicates that a recessive form of EKV has been associated with these homozygous amino-acid
substitutions. (c) Mutations in connexin 30.3: five different missense mutations have been described in
connexin 30.3, all of which have been associated with autosomal-dominant EKV. (d) Mutations in
connexin 30: three different missense mutations have been reported in connexin 30, two of which were
in Clouston’s syndrome (hidrotic ectodermal dysplasia) and one was associated with KID syndrome with
congenital atrichia (indicated by asterisk).
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hyperkeratosis, and alopecia with nor-
mal sweat gland function; some cases
also have sensorineural hearing loss
(Fraser and Der, 2001). The initial
connexin 30 mutations reported by
Lamartine et al. (2000) were p.G11R
and p.A88V, and a further mutation,
p.V37E, in a Scottish case of Clouston
syndrome has also been documented
(Smith et al., 2002). Subsequently, the
missense mutations p.G11R and
p.A88V were identified in several
patients with a clinical diagnosis of
pachyonychia congenita (but lacking
keratin gene pathology) (van Steensel
et al., 2003). Moreover, the mutation
p.V37E has also been reported in a case
of KID syndrome with congenital atri-
chia (Jan et al., 2004). Thus, mutations
in connexin 30 are associated with a
spectrum of phenotypic abnormalities,
although much of this may reflect
differences in descriptive terminology
used by different authors rather than
separate disease entities.
Connexin 43
Mutations in the GJA1 gene, encoding
connexin 43, were first reported in 2001
in nonsyndromic deafness (Liu et al.,
2001) and for a syndrome with protean
ectodermal abnormalities in 2003 (Paz-
nekas et al., 2003). With relevance to
the skin, 16 different missense mutations
(p.Y17S, p.S18P, p.G21R, p.G22E,
p.K23T, p.A40V, p.Q49K, p.R76S,
p.L90V, p.Y98C, p.K102N, p.I130T,
p.K134E, p.G138R, p.R202H, and
p.V216L) and a one codon insertion (154_
156dupTTT) were delineated in indivi-
duals with oculodentodigital dysplasia
(OMIM164200) (Paznekas et al., 2003).
Oculodentodigital dysplasia is an auto-
somal-dominant disorder and its typical
findings are microphthalmos, small
nose, dental anomalies, microcephaly,
developmental abnormalities of the
hands and feet including syndactyly,
brittle nails, and hypotrichosis. Re-
cently, a further case of oculodentodi-
gital dysplasia with an additional
clinical feature of palmoplantar kerato-
derma, resulting from the heterozygous
deletion mutation in connexin 43,
780–781del, has been described (Gong
et al., 2006), along with a further report
of oculodentodigital dysplasia with
curly hair and hyperkeratosis caused
by a missense mutation, p.L11P, on one
allele (Kelly et al., 2006). This study by
Gong et al. (2006) also showed that the
mutant connexin 43 resulted in abnor-
mal gap junction function in keratino-
cytes, thus expanding the spectrum of
connexin genodermatoses.
Adherens junctions
Adherens junctions are electron dense
transmembranous structures that as-
sociate with the actin cytoskeleton
(Vasioukhin and Fuchs, 2001). In their
absence, the formation of other cell–-
cell junctions, such as desmosomes, is
compromised. The extracellular do-
main contains cadherins, such as E-
cadherin, which are responsible for
homotypic, calcium-dependent, adhe-
sive interactions with cadherins on
adjacent cells. Within the cell, cadher-
ins bind to p120ctn, b-catenin, and
plakoglobin. p120ctn promotes cell
migration through recruiting and acti-
vating small GTPases. b-catenin is
normally involved in adherens junction
formation through its ability to bind to
itself and to link cadherins to the actin
cytoskeleton However, b-catenin can
fulfill another role in acting as a
transcriptional cofactor when stimu-
lated by the Wnt signal-transduction
pathway. The first naturally occurring
mutation in a component of adherens
junctions was reported in 2000 in
plakoglobin in individuals with Naxos
disease (McKoy et al., 2000 discussed
in section on desmosomes below) and
thus far the only other human adherens
junction gene mutation with dermato-
logic relevance has involved P-cadher-
in (Sprecher et al., 2001).
P-cadherin
In 2001, a homozygous deletion muta-
tion, c. 981delG, in the CDH3 gene
which encodes the classical cadherin,
P-cadherin, was identified in indivi-
duals with hypotrichosis with juvenile
macular dystrophy (OMIM601553;
Sprecher et al., 2001). This autoso-
mal-recessive disorder is characterized
by early hair loss followed by progres-
sive degeneration of the central retina,
culminating in blindness. P-cadherin is
strongly expressed in both the hair
follicle and retinal pigment epithelium
and the disorder is thought to result
from loss of cell–cell adhesion in hair
follicle and the retina or defective wnt/
b-catenin signaling or a combination of
both mechanisms. Further homozygous
loss-of-function mutations in the CDH3
gene have been reported, comprising
p.L168X, c.462delT, c.829delG, and
c.2112delG (Indelman et al., 2003,
2005). In addition, a homozygous
missense mutation, p.R503H, which
disrupts a critical calcium binding
domain within the fourth extracellular
domain of P-cadherin, has been identi-
fied (Indelman et al., 2002), as well as
two different compound heterozygous
mutations, IVS2þ1G4A and p.E504K,
and p.R221X, and p.H575R (Indelman
et al., 2006). The clinical phenotype of
hypotrichosis with juvenile macular
dystrophy is fairly consistent: children
have short, sparse hair, and progressive
loss of vision and blindness develops
between the first and third decades.
However, the mutation c.829delG, on
both alleles of CDH3, has recently
been reported in a different disorder,
ectodermal dysplasia, ectrodactyly,
macular dystrophy syndrome
(OMIM225280) (Kjaer et al., 2005). In
this autosomal-recessive condition
there is hypotrichosis, macular degen-
eration, hypodontia and limb defects,
including ectrodactyly, syndactyly, and
camptodactyly (Kjaer et al., 2005). A
further homozygous missense mutation
in P-cadherin, p.N322I, has also been
identified in ectodermal dysplasia, ec-
trodactyly, macular dystrophy syn-
drome (Kjaer et al., 2005). The
reasons for the phenotypic disparity
between hypotrichosis with juvenile
macular dystrophy and ectodermal
dysplasia, ectrodactyly, macular dys-
trophy syndrome resulting from the
same or similar mutations in the
CDH3 gene are not known, although
co-inheritance of a mutation in a
neighboring gene such as CDH1 (en-
coding E-cadherin) has been postulated
(Kjaer et al., 2005).
Desmosomes
Desmosomes are important cell–cell
adhesion junctions found predomi-
nantly in the epidermis and the heart
(Green and Gaudry, 2000). Function-
ally, they consist of three families of
proteins, namely the armadillo proteins
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(plakoglobin and certain plakophilins
(PKPs)), cadherins (three desmocollins
and four desmogleins (DSGs)) and
plakins (desmoplakin (DSP), envopla-
kin, periplakin, plectin, bullous pem-
phigoid antigen 1, corneodesmosin
(CDSN), and microtubule actin cross-
linking factor). Desmosomes provide
strength and rigidity to cells and con-
tribute to tissue morphogenesis and
certain cellular processes. The first
human mutations in a desmosome
were identified in the PKP1 gene, in
1997 (McGrath et al., 1997) and
subsequently autosomal-recessive mu-
tations have been identified in DSP,
plakoglobin, and DSG4 (Figure 3).
Autosomal-dominant mutations have
been reported in PKP2, DSP, DSG1
and 2, and CDSN (Figure 3). Collec-
tively, the human mutations demon-
strate the important role of several
desmosomal proteins in skin, hair, and
cardiac development and function.
PKP1
In 1997, McGrath et al. (1997) de-
scribed a child with a combination of
skin fragility and inflammation (ero-
sions, fissures, scale-crust, keratoder-
ma) and abnormalities of ectodermal
development (small size, scanty hair,
reduced sweating, astigmatism) who
was a compound heterozygote for
loss-of-function mutations on both al-
leles of the PKP1 gene, p.Q304X and
c.1132ins28; these mutations occur
within the second and fourth arm-
repeats of the protein (Heid et al.,
1994; Choi and Weis, 2005) (Figure
4a). Clinically, the unique constellation
of signs was termed ectodermal dyspla-
sia-skin fragility syndrome
(OMIM604536). Clues to the desmoso-
mal pathology in this case came from
skin biopsy analysis, which showed
widening of spaces between keratino-
cytes throughout most of the epidermis
(apart from the basal layer) with ultra-
structural evidence of a reduced num-
ber of small, poorly formed desmo-
somes. A candidate gene approach
(based on reduced/absent expression
of desmosomal proteins using immuno-
fluorescence microscopy) was then
used to identify the primary abnormal-
ities in PKP1. Subsequently, eight other
cases of ectodermal dysplasia-skin
fragility syndrome have been reported.
In total, nine different PKP1 mutations
have been published, which include
one nonsense (p.Y71X), one frameshift
(c.888delC) and seven splice site muta-
tions (IVS11G4A, IVS42A4G,
[c.1053T4Aþ IVS5þ 1G4T], IVS6
2A4T, IVS9þ 1G4A, IVS102G4T,
and IVS11þ 1G4A (McGrath et al.,
1999; Whittock et al., 2000; Hamada
et al., 2002; Sprecher et al., 2004;
Steijlen et al., 2004; Zheng et al., 2005;
Ersoy-Evans et al., 2006). Thus, muta-
tions have been found within the
amino terminus as well as the second,
third, fourth, seventh, eighth, and ninth
arm-repeat domains of PKP1. In six of
the nine cases, the mutations have
been homozygous. One splice site
mutation, IVS11G4A, has been re-
ported in two different families (on one
allele in a British patient; on both
alleles in an Israeli case) (McGrath
et al., 1999; Sprecher et al., 2004).
From the few mutations reported,
limited genotype–phenotype correla-
tion has been possible, although the
case reported by Steijlen et al. (2004)
highlighted a slightly milder clinical
variant of the syndrome, perhaps due to
presence of at least one in-frame
transcript arising from the homozygous
splice site mutation, IVS9þ1G4A. In
addition, the hypohidrosis reported in
the original case (McGrath et al., 1997)
has not been a persistent feature in
clinical follow-up of this patient nor
any of the other descriptions of ecto-
dermal dysplasia-skin fragility syn-
drome. Collectively, the loss-of-
function mutations in PKP1 and cell
biologic studies on keratinocytes lack-
ing PKP1, demonstrate the importance
of PKP1 in the formation of desmoso-
mal plaques and in stabilizing desmo-
somal proteins (South et al. 2003).
AUTOSOMAL
DOMINANT
AUTOSOMAL
RECESSIVE
Arrhythmogenic
right ventricular
cardiomyopathy
Woolly hair,
keratoderma,
cardiomyopathy
Arrhythmogenic
right ventricular
cardiomyopathy
Striate
palmoplantar
keratoderma
Striate
palmoplantar
keratoderma
Arrhythmogenic
right ventricular
cardiomyopathy
Hypotrichosis
simplex
Localized
recessive
hypotrichosis
Naxos
disease
Lethal
acantholytic
epidermolysis
bullosa
Woolly hair,
keratoderma,
+/– cardiomyopathy
Skin fragility
ectodermal dysplasia
syndrome
PLAKOPHILIN 1
PLAKOPHILIN 2
PLAKOGLOBIN
DESMOPLAKIN
DESMOGLEIN 1
DESMOGLEIN 2
DESMOGLEIN 4
CORNEODESMOSIN
Recessive
monilethrix
Figure 3. Illustration of the autosomal-dominant and -recessive disease phenotypes associated with
inherited mutations in structural components of desmosomes. Mutations in five proteins are associated
with dominant diseases: PKP2, DSP, DSG1, DSG2, and CDSN, whereas mutations in four proteins, PKP1,
DSP, plakoglobin, and DSG4 have been detected in autosomal-recessive disorders. Only DSP may
harbor both dominant and recessive pathogenic mutations.
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PKP1 has been shown to bind to DSG1,
desmocollin 1, DSP, keratin (at least in
vitro) and actin (Hatzfeld, 2006), and in
the skin of patients with ectodermal
dysplasia-skin fragility syndrome, there
is altered distribution of DSP, providing
direct evidence for the in vivo associa-
tion between PKP1 and DSP (McGrath
et al. 1997). PKP1 also localizes to
nuclei as well as desmosomes, includ-
ing in several tissues that do not
contain desmosomes. The PKP1a iso-
form can associate with desmosomes or
localize to the nucleus whereas PKP1b
has an exclusively nuclear localization
(Schmidt et al., 1997). However, the
role of PKP1 in intranuclear signaling
has not been established and how or
whether such a role contributes to the
ectodermal dysplasia phenotype re-
mains speculative.
PKP2
Heterozygous mutations in the PKP2
gene (PKP2) represent the major cause
of familial arrhythmogenic ventricular
cardiomyopathy (ARVC) (van Tintelen
et al., 2006). ARVC is an autosomal-
dominant condition characterized by
ventricular arrhythmias, syncope, and
sudden death usually precipitated by
exertion (Thiene et al., 1988). The
disorder affects about one in 1250
people and 50–80% of cases are
familial (Peters, 2006); non-familial
cases do not usually involve PKP2
mutations (van Tintelen et al., 2006).
Expression of ARVC occurs by adoles-
cence and penetrance is approximately
55% (Antoniades et al., 2006). Histo-
logically, the myocardium is replaced
by a fibrofatty infiltration and an
inflammatory infiltrate, mainly in the
right ventricle, apex, inflow, and out-
flow tracts. The left ventricle can be
affected in up to 50% of cases (MacRae
et al., 2006). The first PKP2 mutations
in ARVC were reported in 2004 (Gerull
et al., 2004): 24 different mutations
(nonsense, frameshift, splice site, and
missense) were identified in 32 differ-
ent individuals, with the mutation
p.R79X representing a recurrent muta-
tion in several individuals. Several
other mutations in familial ARVC have
been subsequently identified (Anto-
niades et al., 2006; Peters, 2006),
although no particular cutaneous ab-
normalities have been reported in any
individual with PKP2 gene pathology.
Clinical symptoms associated with
ARVC in individuals with heterozygous
mutations in PKP2 are very variable,
from no symptoms to tachycardia,
syncope, and sudden death, although
electrocardiographic abnormalities
(e.g. T wave inversion and QRS disper-
sion) are typically present (Syrris et al.,
2006). Involvement of the left ventricle
may be an independent risk factor for
sudden death (Antoniades et al., 2006).
DSP
The first evidence for a human
inherited abnormality of DSP, emerged
from a linkage study, that mapped an
IVS1-1G>A
IVS9+1G>Aa
b
c
d
IVS11+1G>A
IVS10-2G>T
IVS6-2A>TIVS4-2A>G
IVS7+1G>A c.1822ins30 p.R1934X c.6370delTT
c.7901delGp.R1775I
p.S299R
p.N287K p.C809X p.R1267X p.G2375A
p.R2366Cp.Q664X
p.R26X
IVS2-1G>A c.121insT c.1079insC
EX5_8del
p.A129S
p.S192P p.R289X
p.P267R
c.763delT
IVS3+1G>T
c.2039insT
c.1189delA
p.S132X p.Y365X c.1627delA
p.R1255KIVS3-1G>A
c.2034insAp.Q331X
[c.1053T>A + IVS5+1G>A]
p.Y71X c.888delC p.Q304X c.1132ins28
Figure 4. Mutation spectrum and disease phenotypes for the desmosomal proteins PKP1, DSP, DSG 1
and 4. (a) Mutations in PKP1: 11 different loss-of-function mutations have been reported all of which are
associated with skin fragility-ectodermal dysplasia syndrome. (b) Mutations in DSP: 17 different
mutations have been reported and lead to various clinical abnormalities comprising striate palmoplantar
keratoderma (dark blue arrows); Carvajal syndrome (pink arrows); woolly hair and keratoderma (purple
arrows), arrhythmogenic right ventricular cardiomyopathy (green arrows); woolly hair, keratoderma/
blisters, cardiomyopathy/Carvajal-like disorder (brown arrows); and lethal acantholytic epidermolysis
bullosa (light blue arrows). (c) Mutations in DSG1: eight autosomal-dominant mutations have been
described, most of which lead to striate palmoplantar keratoderma (purple arrows), although one case of
focal keratoderma with additional non-acral hyperkeratosis has been reported (blue arrow). (d) Mutations
in DSG4: eight different recessive mutations have been identified in either recessive localized
hypotrichosis (green arrows) or recessive monilethrix (purple arrows). (Single unconnected arrows
represent autosomal-dominant mutations; double arrows indicate homozygous-recessive mutations;
joined arrows depict compound heterozygous-recessive mutations).
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autosomal-dominant pedigree with stri-
ate palmoplantar keratoderma (SPPK)
to 6p24, a locus containing the DSP
gene (Armstrong et al., 1999) (Figure
4b). Electron microscopy of palmar
skin showed dysadhesion between su-
prabasal keratinocytes with abnormal
cell–cell and cell membrane-cytoskele-
tal adhesion and screening of genomic
DNA from affected family members
identified a heterozygous nonsense
mutation, p.Q331X, in the DSP gene
(Armstrong et al., 1999). Thus SPPK in
this family was due to DSP haploinsuf-
ficiency, demonstrating that 50% of
normal DSP levels is sufficient for
normal epidermal functioning in non-
palmoplantar skin but that this amount
of DSP is not sufficient to withstand
trauma to the palms and soles without
resulting in an abnormal phenotype. A
second pedigree with SPPK associated
with DSP haploinsufficiency was sub-
sequently described, the pathogenic
abnormality being a heterozygous do-
nor splice site mutation, IVS7þ1G4A.
(Whittock et al., 1999). The first reces-
sive pathogenic mutation found in the
DSP gene was a homozygous frame-
shift mutation, c.7901delG, identified
in affected members of three Ecuador-
ean families (Norgett et al., 2000) with
Carvajal syndrome (OMIM605676),
which comprises palmoplantar kerato-
derma, dilated left ventricular cardio-
myopathy, and woolly hair (Carvajal-
Huerta, 1998). This mutation produces
a stop codon leading to the formation
of a truncated protein lacking the
carboxyl terminal tail domain. In this
syndrome, affected patients suffer from
heart failure in their teens and the skin
abnormalities are usually confined to
areas prone to mechanical stress such
as the palms and soles. Contrastingly,
the almost complete ablation of the
DSP tail may produce an even more
severe phenotype consisting of progres-
sive widespread epidermolysis asso-
ciated with generalized alopecia,
absence of nails, and the presence of
neonatal teeth (Jonkman et al.,
2005). This condition, termed ‘‘lethal
acantholytic epidermolysis bullosa’’
(OMIM609638) has been described in
a single neonate who was a compound
heterozygote for two novel mutations
in the DSP gene, p.R1934X, and
c.6370delTT. Further homozygous mis-
sense (p.G2375R) and nonsense
(p.R1267X) mutations in the DSP gene
have also been reported (Alcalai et al.,
2003; Uzumcu et al., 2006): the
phenotype in affected individuals in-
volves abnormalities in the skin (blis-
ters or palmoplantar keratoderma), hair
(woolly), and heart (arrhythmogenic
right ventricular cardiomyopathy). The
mutation p.R1267X specifically trun-
cates the DSPI isoform of DSP: alter-
native splicing of DSP creates two DSP
transcripts, a larger DSPI and a smaller
DSPII, with both isoforms contributing
to the organization of the cadherin–-
plakoglobin complex (Smith and Fuchs,
1998; Kowalczyk et al., 1999), but only
DSPI is found in cardiac tissue (Angst
et al., 1990). Another recessive DSP
phenotype, consisting of keratoderma,
woolly hair, and nail dystrophy but
without cardiac abnormalities, has
been described and termed ‘‘skin fra-
gility-woolly hair syndrome’’
(OMIM607655) (Whittock et al.,
2002). Two unrelated cases were found
to be compound heterozygotes for
different combinations of nonsense/
missense mutations in DSP, p.C809X/
p.N287K, and p.Q664X/p.R2366C.
Heterozygous carriers of the respective
nonsense mutations in these families,
however, had no phenotypic abnorm-
alities, an unexpected observation gi-
ven the two earlier reports of DSP
haploinsufficiency in SPPK (Armstrong
et al. 1999; Whittock et al., 1999).
Heterozygous carriers of the respective
missense mutations also have no phe-
notypic abnormalities, although a number
of other autosomal-dominant missense
mutations (p.S299R, p.R1255K, and
p.R1775I) have been reported in pedi-
grees with ARVC (right or left ventri-
cular involvement) (Rampazzo et al.,
2002; Bauce et al., 2005) and similar
disorders have been described for the
heterozygous mutations IVS31G4A
(Bauce et al., 2005) and c.2034insA
(Norman et al., 2005). One further
heterozygous mutation in the DSP gene
has been reported, an insertion of 10
amino-acid residues, starting in codon
608, designated c.1822ins30 (Norgett
et al., 2006), in which the clinical
features comprised ARVC, woolly hair
and PPK. Thus far, 17 different muta-
tions have been reported in the DSP
gene. These comprise five nonsense,
six missense, four frameshift, and two
splice site mutations. Clinically, muta-
tions in DSP result in a variable
combination of skin, hair, and cardiac
abnormalities. The pattern of the kera-
toderma is not always ‘‘striate’’: some-
times it appears more focal, sometimes
more diffuse. Moreover, the age of
onset is variable and the degree of
trauma to the palms and soles clearly
has an influence on the clinical severity
and presentation. The subtype of car-
diomyopathy is also variable, with
different degrees of right ventricular
(as in most reports) or left ventricular
involvement. Nevertheless, often both
ventricles show dysfunctional abnorm-
alities and premature cardiac death
(from arrhythmia) is common to nearly
all cases with myocardial involvement.
Plakoglobin
Only one pathogenic mutation in the
human plakoglobin gene (JUP) has
been reported (McKoy et al., 2000). A
homozygous 2-base pair deletion,
c.2157delTG, was shown to be the
cause of an autosomal-recessive dis-
order involving heart, skin, and hair
abnormalities known as Naxos disease
(OMIM601214), following an earlier
report that mapped this condition to
17q21 (Coonar et al., 1998). Moreover,
plakoglobin-deficient transgenic mice
had been shown to have severe cardiac
defects and, in those that survived, skin
fragility was observed (Bierkamp et al.,
1996) and thus the JUP gene repre-
sented an attractive candidate for a
human cardiocutaneous syndrome.
The clinical features of Naxos disease
comprise ARVC, nonepidermolytic dif-
fuse PPK, and irregular woolly hair. The
disorder is named after the Mediterra-
nean island Naxos on which approxi-
mately 1 in 1,000 of the population are
affected (Antoniades et al., 2006),
although additional cases have been
documented on the neighboring island
of Milos and in Bologna (Italy). In total,
approximately 30 cases have been
reported and all have the same
mutation. The mutation c.2157delTG
occurs close to the carboxyl terminus
of plakoglobin and alters the last
five amino acids within the 13th
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arm-repeat, truncating the protein by
56 residues. The dermatologic features
of PPK and woolly hair are present in
all individuals who are homozygous for
the c.2157delTG mutation with no
reports of skin or hair abnormalities in
heterozygous carriers. In homozygous
individuals, over 90% have electrocar-
diographic abnormalities compared to
about 25% of heterozygous carriers
(who have mostly T wave inversion in
the V1–V3 leads). Cardiac features in
homozygous subjects include arrhy-
thmias, syncope, heart failure, and
sudden death but heterozygotes show
no overall increased cardiac morbidity
or mortality (Antoniades et al., 2006).
DSG1
Abnormalities in the DSG1 gene in an
inherited skin disorder were first iden-
tified in 1999. Rickman et al. (1999)
mapped a three-generation Dutch fa-
mily with SPPK to 18q12.1 and identi-
fied a heterozygous acceptor splice site
mutation, IVS21G4A, in the DSG1
gene (Figure 4c). This mutation occurs
within the prosequence of DSG1 but
results in skipping of exons 2–4 and
generating a peptide that is only 25
amino acids in length. This finding
suggests that the SPPK in this family
(OMIM148700) is due to haploinsuffi-
ciency of DSG1. Six further mutations
in DSG1, p.R26X, p.S132X
c.1079insC, p.Y365X, c.1189delA,
and c.1627delA were then reported
(Hunt et al., 2001; Kljuic et al.,
2003b). All of these mutations are
located within the extracellular part of
DSG1. Clinically, affected individuals
had features of SPPK, but none had any
abnormalities in nonpalmoplantar skin
or skin appendages, including hair.
Although dominant-negative interfer-
ence between the wild-type and mu-
tant alleles could not be completely
discounted, the disease pathophysiol-
ogy in all these cases was presumed to
be due to DSG1 haploinsufficiency.
Subsequently, the mutation p.R26X
was also reported in an Israeli pedigree
with autosomal-dominant keratoderma
(Keren et al., 2005). However, the
pattern of skin thickening on the palms
in this family was not striate. Rather,
affected individuals had diffuse non-
epidermolytic PPK although there was
no involvement of other skin sites. In
contrast, Milingou et al. (2006) de-
scribed an individual with DSG1 hap-
loinsufficiency, owing to a hetero-
zygous frameshift mutation, c.121insT,
who had clinical features of focal
(rather than striate) PPK as well as skin
thickening/scaling on trauma-prone
sites such as the knees, ankles, or finger
knuckles; the patient also had mild nail
dystrophy. Clearly, in all cases of DSG1
mutations, trauma has a significant
impact on disease expression and
severity. Mutations in the DSG1 gene
also affect the number and size of
desmosomes as well as expression of
other skin proteins (Wan et al., 2004).
Notably, in palmar skin, DSG1 hap-
loinsufficiency leads to a reduced
number of smaller desmosomes in
suprabasal layers. By confocal micro-
scopy, there is reduced expression of
keratins K5, K14, and K10 and upregu-
lation of K16; involucrin labeling is
also disrupted (Wan et al., 2004).
DSG2
The first pathogenic mutations in the
human gene (DSG2) were identified in
2006 (Awad et al., 2006; Pilichou
et al., 2006). Given the predominant
localization of DSG2 in cardiac myo-
cytes and the earlier descriptions of
mutations in the desmosomal proteins
DSP, JUP, and PKP2 in individuals and
families with ARVC, the DSG2 gene
represented a plausible candidate for
mutations in unclassified cases. Four-
teen mutations were identified:
p.R45Q, p.R48H, p.Y87C, p.G100R,
p.N266S, p.K294E, p.W305X, p.E331K,
c.1253insATGA, IVS122A4G, p.C506Y,
c.2036delG, p.Q558X, and p.G811C
(Awad et al., 2006; Pilichou et al., 2006).
Most of these were dominantly inherited.
However, the mutation p.E331K oc-
curred on the same allele as the splice
site mutation IVS122A4G and may
therefore represent a rare missense
polymorphism. In addition, two of the
mutations occurred in one individual
who was a compound heterozygote for
p.R48H and p.W304X. This individual
also had a history of an episode of
erythema multiforme/Stevens–Johnson
syndrome associated with extensive
mucosal ulceration, as well as a sepa-
rate episode of a severe postoperative
wound infection (Awad et al., 2006).
However, none of the other individuals
in either report had any recorded skin,
hair, or mucosal abnormalities. Most of
the pathogenic mutations identified are
located within the extracellular adhe-
sive domain of DSG2. The clinico-
pathological features of ARVC in
individuals with DSG2 mutations are
similar to those cases with mutations in
other desmosomal components, with
left ventricular involvement in up to
50% of affected subjects. Overall, it
appears that DSG2 mutations account
for about 5–10% of all cases of ARVC
and that, collectively, mutations in
structural components of the desmoso-
mal complex provide the genetic basis
for approximately 40% of ARVC.
DSG4
The first inherited disorder owing to
mutations in the DSG4 gene was
identified in 2003 (Kljuic et al.,
2003a). A homozygous intragenic de-
letion was shown to be the cause of
localized autosomal-recessive hypotri-
chosis (OMIM607903) (Figure 4d),
although this disorder appears to be
genetically heterogeneous with other
cases mapping to chromosome 3q
(Aslam et al., 2004). Clinically, affected
individuals have hypotrichosis invol-
ving the scalp, chest, arms, and legs,
but there is sparing of the axillary and
pubic hair and eyelashes. On the scalp,
small papules are present owing to the
inability of the hair to extrude through
the skin (Kljuic et al., 2003a). The
deletion mutation first identified,
EX5–8del, has been shown to be a
recurrent mutation in several Pakistani
families (Moss et al., 2004; Rafiq et al.,
2004; John et al., 2006; Kljuic et al.,
2003a). This mutation deletes all of the
second extracellular domain as well as
part of the first and third extracellular
domains. A homozygous missense muta-
tion, p.A129S, has also been reported in
an Iraqi subject with localized autoso-
mal-recessive hypotrichosis (Messenger
et al., 2005). This amino-acid substitution
is located within a highly conserved motif
(RAL) corresponding to the HAV region
of classical cadherins, a domain that is
important in cell adhesion. In 2006,
further missense (p.P267Rp.S192P),
splice site (IVS3þ 1G4T), frameshift
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(c763delT; c.2039insT), and nonsense
(p.R298X) mutations in the DSG4 gene
were reported (Schaffer et al., 2006;
Shimomura et al., 2006; Zlotogorski
et al., 2006). However, the phenotype
in these cases was described as auto-
somal-recessive monilethrix. Although
the beaded hair phenotype of monilethrix
typically presents as an autosomal-domi-
nant disorder (OMIM158000) owing to
heterozygous mutations in the hair
keratin genes, KRTHB1, KRTHB3, and
KRTHB6, recessive forms of the disease
also exist and these appear to result from
mutations on both alleles of DSG4. The
six different autosomal-recessive muta-
tions that have been reported were
described in individuals from Iran, Iraq,
Morocco, and Japan (Schaffer et al.,
2006; Shimomura et al., 2006; Zlotogors-
ki et al., 2006). One of these mutations,
p.P267R, appears to be a recurrent
mutation in the Jewish Iraqi population
(Schaffer et al., 2006; Zlotogorski et al.,
2006). Five of the mutations are located
within the extracellular part of DSG4,
either in the pre-protein domain or in the
first two extracellular domains, and one
mutation (c.2039insT) occurs within the
transmembranous region. Although loca-
lized autosomal-recessive hypotrichosis
and recessive monilethrix are listed as
distinct entities, some phenotypic overlap
exists and the nature of the mutations in
the extracellular part of DSG4 also shows
similar gene pathologies.
CDSN
Within cornifying squamous epithelia,
one additional desmosomal compo-
nent is CDSN, a glycoprotein that is
also expressed in the inner toot sheath
of the hair follicle. In 2003, heterozy-
gous nonsense mutations in the CDSN
gene, were identified in individuals with
the autosomal-dominant disorder hypo-
trichosis simplex (OMIM146520) (Levy-
Nissenbaum et al., 2003). In this
condition, hair is usually normal at birth
but progressive thinning of scalp hair
starts within the first decade and is
almost complete by the third decade;
other body sites are not affected.
Affected individuals within an Israeli
and a Spanish family were heterozygous
for the mutation p.Q215X, whereas the
CDSN gene pathology in a Danish
family involved the heterozygous non-
sense mutation p.Q200X. A third non-
sense mutation, p.Y239X, has also been
reported in a Mexican pedigree with
hypotrichosis simplex (Da´valos et al.,
2005) Histologically, there is a loss of
cohesion in the inner root sheaths.
Moreover, proteolytically cleaved ag-
gregates of abnormal CDSN accumulate
around hair follicles and in the super-
ficial dermis and it has been suggested
that these aggregates are toxic to the
hair follicle cells and that hypotrichosis
simplex of the scalp is a disease
associated with protein misfolding
(Levy-Nissenbaum et al., 2003).
Conclusion
The identification of a large number of
naturally occurring human mutations in
genes encoding proteins that contribute
to intercellular junctions has provided
a fascinating insight into the etiology of
a spectrum of inherited diseases, many
with rare and unusual phenotypes.
Delineating particular mutations has
also led to valuable new data on the
functional role of specific domains of
certain proteins in both health and
disease states, as well as providing
new ideas and opportunities for both
basic and translational research.
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